Literature DB >> 2566049

Retrovirus-like sequences in Graves' disease: implications for human autoimmunity.

A Ciampolillo1, V Marini, R Mirakian, M Buscema, T Schulz, R Pujol-Borrell, G F Bottazzo.   

Abstract

On Southern blotting of DNA extracted from thyroid glands of five patients with Graves' disease, two probes (720 bp and 942 bp) for gag human immunodeficiency virus type 1 (HIV-1) gave a positive hybridisation signal in all samples tested. DNAs from peripheral blood mononuclear cells hybridised with the 720 bp gag HIV-1 probe in three of the five patients, none of whom had antibodies to HIV-1. Negative results were obtained with DNA from normal thyroid glands, thyroid neoplasms, various unrelated normal tissues, and virus-infected human cell lines. The intensity of the signal and the pattern of bands observed with the DNA of Graves' patients were heterogeneous and, in general, were not the same in the thyroid glands and peripheral blood mononuclear cells of individual patients. Similarly, no correlation was found between the positive hybridisation signals and other genetic and immunological indices or the duration of anti-thyroid drug treatment at the time the patients were investigated. The findings suggest the presence of a novel retrovirus, and the retrovirus-like sequences seem to be closely associated with thyroid autoimmunity.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2566049     DOI: 10.1016/s0140-6736(89)92382-9

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  21 in total

Review 1.  Are the inflammatory bowel diseases autoimmune disorders?

Authors:  J Snook
Journal:  Gut       Date:  1990-09       Impact factor: 23.059

2.  Human cervical epithelial cells that express HLA-DR associated with viral infection and activated mononuclear cell infiltrate.

Authors:  S Fais; F Delle Fratte; F Mancini; V Cioni; M Guadagno; G Vetrano; F Pallone
Journal:  J Clin Pathol       Date:  1991-04       Impact factor: 3.411

3.  High prevalence of serum antibodies to hepatitis C virus in patients with Hashimoto's thyroiditis.

Authors:  J C Duclos-Vallée; C Johanet; J C Trinchet; P Deny; M F Laurent; F Duron; P Valensi; B Weil; J C Homberg; D Pateron
Journal:  BMJ       Date:  1994-10-01

Review 4.  Role of genetic and non-genetic factors in the etiology of Graves' disease.

Authors:  M Marinò; F Latrofa; F Menconi; L Chiovato; P Vitti
Journal:  J Endocrinol Invest       Date:  2014-11-25       Impact factor: 4.256

5.  High frequencies of human T-lymphotropic virus type I (HTLV-I) infection and presence of HTLV-II proviral DNA in blood donors with anti-thyroid antibodies.

Authors:  H Mine; H Kawai; K Yokoi; M Akaike; S Saito
Journal:  J Mol Med (Berl)       Date:  1996-08       Impact factor: 4.599

6.  Evidence of HTLV-I in thyroid tissue in an HTLV-I carrier with Hashimoto's thyroiditis.

Authors:  H Kawai; T Mitsui; K Yokoi; M Akaike; K Hirose; K Hizawa; S Saito
Journal:  J Mol Med (Berl)       Date:  1996-05       Impact factor: 4.599

7.  Hyperthyroidism of Graves' disease: evidence for only unilateral involvement of the thyroid gland in a 31-year-old female patient.

Authors:  H P Dimai; S Ramschak-Schwarzer; S Lax; R W Lipp; G Leb
Journal:  J Endocrinol Invest       Date:  1999-03       Impact factor: 4.256

8.  Is there anything to the reported association between Helicobacter pylori infection and autoimmune thyroiditis?

Authors:  Paolo A Tomasi; Maria P Dore; Giuseppe Fanciulli; Franca Sanciu; Giuseppe Realdi; Giuseppe Delitala
Journal:  Dig Dis Sci       Date:  2005-02       Impact factor: 3.199

9.  Abnormal urothelial HLA-DR expression in interstitial cystitis.

Authors:  T J Christmas; G F Bottazzo
Journal:  Clin Exp Immunol       Date:  1992-03       Impact factor: 4.330

10.  Human spumaretrovirus-related sequences in the DNA of leukocytes from patients with Graves disease.

Authors:  S Lagaye; P Vexiau; V Morozov; V Guénebaut-Claudet; J Tobaly-Tapiero; M Canivet; G Cathelineau; J Périès; R Emanoil-Ravier
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.